.Flagship Pioneering has unveiled a new start-up that aims to find, then drug, targets that are specific to different states of diseases. The company, Etiome, will begin with metabolic, neurodegenerative, and inflammatory illnesses. cen.acs.org/business/start…

With a new raise provided by Flagship Pioneering, the new company is aiming to find “the silent window” before disease symptoms set in. hubs.li/Q03jHpRQ0

Etiome, a new Flagship startup, looks to catch disease before it strikes biopharmadive.com/news/etiome-fl… by Gwendolyn Wu #biotech #startups Flagship Pioneering

A new Cambridge biotech is creating a roadmap to expand preventive health to a broader range of diseases, treating patients before they become irreversibly ill. bizjournals.com/boston/news/20…

Aiming for Earlier Intervention, Flagship Startup Etiome Emerges to Define ‘Biostages’ of Disease medcitynews.com/2025/04/precis…

Flagship Pioneering has unveiled a new start-up that aims to find, then drug, targets that are specific to different states of diseases. The company, Etiome, will begin with metabolic, neurodegenerative, and inflammatory illnesses. cen.acs.org/business/start…

At Etiome, we build and apply detailed models of how biology shifts over the course of disease based on vast amounts of patient data, revealing new insights and opportunities to slow, stop or even prevent disease. Listen: bit.ly/4kGDB7F

We’re thrilled to welcome Sandra Engle as our new Head of Biology! Sandi brings a wealth of experience in translational science, target validation, and platform-driven discovery. Her leadership will be instrumental as we work to develop preemptive medicines for better health.